Skip to content

Circles

V

Voyager Therapeutics, Inc.

VYGR· Nasdaq

V

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.·Earnings record

Q3 2014

Source filing unavailable

Previous · Q2 2014 Next · Q4 2014

Q3 2014 · —

Revenue—

Net Income

-$4.01M

no prior Q3 2013 on file

EPS Diluted

$6.45

no prior Q3 2013 on file

Operating Income-$3,656,000—

Same quarter

no prior Q3 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’14 Q2 ’14Q3 ’14Q4 ’14 Q1 ’15 Q2 ’15 Q3 ’15 Q4 ’15 Q1 ’16…

Voyager Therapeutics, Inc. · CIK 1640266 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy